Influence of Erroneous Patient Records on Population Pharmacokinetic Modeling and Individual Bayesian Estimation

被引:9
|
作者
van der Meer, Aize Franciscus [1 ]
Touw, Daniel J. [2 ]
Marcus, Marco A. E. [1 ]
Neef, Cornelis [3 ]
Proost, Johannes H. [4 ]
机构
[1] Maastricht Univ, Med Ctr, Dept Anesthesiol, NL-6202 AZ Maastricht, Netherlands
[2] Cent Hosp Pharm, The Hague, Netherlands
[3] Maastricht Univ, Med Ctr, Dept Clin Pharm, NL-6202 AZ Maastricht, Netherlands
[4] Univ Groningen, Univ Ctr Pharm, Dept Pharmacokinet Toxicol & Targeting, Groningen, Netherlands
关键词
maximum a posteriori Bayesian estimation; pharmacokinetics; population modeling; patient records; error identification; PERFORMANCE; VANCOMYCIN; SIMULATION;
D O I
10.1097/FTD.0b013e3182616937
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Observational data sets can be used for population pharmacokinetic (PK) modeling. However, these data sets are generally less precisely recorded than experimental data sets. This article aims to investigate the influence of erroneous records on population PK modeling and individual maximum a posteriori Bayesian (MAPB) estimation. Methods: A total of 1123 patient records of neonates who were administered vancomycin were used for population PK modeling by iterative 2-stage Bayesian (ITSB) analysis. Cut-off values for weighted residuals were tested for exclusion of records from the analysis. A simulation study was performed to assess the influence of erroneous records on population modeling and individual MAPB estimation. Also the cut-off values for weighted residuals were tested in the simulation study. Results: Errors in registration have limited the influence on outcomes of population PK modeling but can have detrimental effects on individual MAPB estimation. A population PK model created from a data set with many registration errors has little influence on subsequent MAPB estimates for precisely recorded data. A weighted residual value of 2 for concentration measurements has good discriminative power for identification of erroneous records. Conclusions: ITSB analysis and its individual estimates are hardly affected by most registration errors. Large registration errors can be detected by weighted residuals of concentration.
引用
收藏
页码:526 / 534
页数:9
相关论文
共 50 条
  • [21] Influence of renal function estimation on pharmacokinetic modeling of vancomycin in elderly patients
    Glatard, A.
    Bourguignon, L.
    Maire, P.
    Goutelle, S.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2014, 28 : 39 - 39
  • [22] Population pharmacokinetic modeling of gentamicin in pediatric patients and assessment of age influence
    Wang, Yuhuan
    Liu, Xiaoxi
    Korgenski, E. Kent
    Sherwin, Catherine M. T.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2016, 43 : S83 - S84
  • [23] Infliximab population pharmacokinetic modelling in patients with Inflammatory Bowel Disease: estimation of individual pharmacokinetic parameters and trough levels prediction
    Guardiola, J.
    Rodriguez-Alonso, L.
    Santacana, E.
    Padulles, N.
    Colom, H.
    Padulles, A.
    Ruiz-Cerulla, A.
    Arajol, C.
    Cobo, S.
    Bas, J.
    Climent, J.
    Morandeira, F.
    Rodriguez-Moranta, F.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S320 - S321
  • [24] Population Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet?
    Brooks, Emily
    Tett, Susan E.
    Isbel, Nicole M.
    Staatz, Christine E.
    CLINICAL PHARMACOKINETICS, 2016, 55 (11) : 1295 - 1335
  • [25] Population Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet?
    Emily Brooks
    Susan E. Tett
    Nicole M. Isbel
    Christine E. Staatz
    Clinical Pharmacokinetics, 2016, 55 : 1295 - 1335
  • [26] HIERARCHICAL BAYESIAN PARAMETER ESTIMATION FOR MODELING AND ANALYSIS OF USER AFFECTIVE INFLUENCE
    Zhou, Feng
    Jiao, Jianxin
    PROCEEDINGS OF THE ASME INTERNATIONAL DESIGN ENGINEERING TECHNICAL CONFERENCES AND COMPUTERS AND INFORMATION IN ENGINEERING CONFERENCE, 2013, VOL 3B, 2014,
  • [27] A Bayesian Approach for Population Pharmacokinetic Modeling of Pegylated Interferon α-2a in Hepatitis C Patients
    Mohammad I. Saleh
    Clinical Pharmacokinetics, 2017, 56 : 1369 - 1379
  • [28] Bayesian Approach for Population Pharmacokinetic Modeling of Pegylated Interferon α-2a in Hepatitis C Patients
    Saleh, Mohammad I.
    CLINICAL PHARMACOKINETICS, 2017, 56 (11) : 1369 - 1379
  • [29] Modeling Patient Visit Using Electronic Medical Records for Cost Profile Estimation
    Zhao, Kangzhi
    Zhang, Yong
    Wang, Zihao
    Yin, Hongzhi
    Zhou, Xiaofang
    Wang, Jin
    Xing, Chunxiao
    DATABASE SYSTEMS FOR ADVANCED APPLICATIONS (DASFAA 2018), PT II, 2018, 10828 : 20 - 36
  • [30] Bayesian estimation of a cancer population by capture-recapture with individual capture heterogeneity and small sample
    Laurent Bailly
    Jean Pierre Daurès
    Brigitte Dunais
    Christian Pradier
    BMC Medical Research Methodology, 15